BioMarin to Participate in Two Upcoming Investor Conferences

On November 3, 2022 BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported that management will present at two upcoming investor conferences (Press release, BioMarin, NOV 3, 2022, View Source2022-11-03-BioMarin-to-Participate-in-Two-Upcoming-Investor-Conferences" target="_blank" title="View Source2022-11-03-BioMarin-to-Participate-in-Two-Upcoming-Investor-Conferences" rel="nofollow">View Source [SID1234623017]). To access the live webcasts, please visit: View Source . An archived version of the presentations will also be available through the Company’s website for a limited time following the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!